Ameritas Investment Partners, Inc. Aeglea Bio Therapeutics, Inc. Transaction History

Ameritas Investment Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.5 - $2.66 $1,855 - $9,868	-3,710 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$4.01 - $11.04 $5,477 - $15,080	1,366 Added 58.28%	3,710 $34,000
Q1 2020 May 13, 2020	BUY	$3.51 - $8.48 $3,387 - $8,183	965 Added 69.98%	2,344 $11,000
Q2 2018 Aug 13, 2018	BUY	$7.87 - $10.89 $10,852 - $15,017	1,379 New	1,379 $15,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.